SC
Saturna Capital Portfolio holdings
AUM
$7.4B
1-Year Return
15.42%
This Quarter Return
+13.82%
1 Year Return
+15.42%
3 Year Return
+97.93%
5 Year Return
+168.95%
10 Year Return
+454.25%
AUM
$6.42B
AUM Growth
+$762M
(+13%)
Cap. Flow
+$60.6M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
41.81%
Holding
187
New
13
Increased
56
Reduced
62
Closed
16
Top Buys
| 1 |
Broadcom
AVGO
|
$59.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$37.6M |
| 3 |
Johnson Controls International
JCI
|
$23.1M |
| 4 |
Microsoft
MSFT
|
$18.8M |
| 5 |
Oracle
ORCL
|
$15.6M |
Top Sells
| 1 |
Corteva
CTVA
|
$62.7M |
| 2 |
Eli Lilly
LLY
|
$28.5M |
| 3 |
Estee Lauder
EL
|
$24.9M |
| 4 |
3M
MMM
|
$16.9M |
| 5 |
Norfolk Southern
NSC
|
$5.67M |
Sector Composition
| 1 | Technology | 42.94% |
| 2 | Healthcare | 24.13% |
| 3 | Industrials | 13.9% |
| 4 | Consumer Discretionary | 7.85% |
| 5 | Consumer Staples | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Toronto Dominion Bank
TD
$127B
| $291K | ﹤0.01% |
4,500
| – | – |
|
152
Freeport-McMoran
FCX
$66.5B
| $290K | ﹤0.01% |
6,813
| – | – |
|
153
Rambus
RMBS
$8.05B
| $284K | ﹤0.01% |
+4,167
| New | +$284K |
|
154
CGI
GIB
$21.6B
| $284K | ﹤0.01% |
+2,650
| New | +$284K |
|
155
Chevron
CVX
$310B
| $276K | ﹤0.01% |
1,852
| – | – |
|
156
JPMorgan Chase
JPM
$809B
| $274K | ﹤0.01% |
1,608
| – | – |
|
157
Elastic
ESTC
$9.21B
| $269K | ﹤0.01% |
2,389
-88
| -4% | -$9.92K |
|
158
Intel
INTC
$107B
| $260K | ﹤0.01% |
+5,184
| New | +$260K |
|
159
Micron Technology
MU
$147B
| $252K | ﹤0.01% |
2,950
| – | – |
|
160
Clorox
CLX
$15.5B
| $246K | ﹤0.01% |
1,725
-185
| -10% | -$26.4K |
|
161
SiTime
SITM
$6.1B
| $245K | ﹤0.01% |
2,008
-62
| -3% | -$7.57K |
|
162
Verizon
VZ
$187B
| $236K | ﹤0.01% |
6,260
| – | – |
|
163
Mid-America Apartment Communities
MAA
$17B
| $236K | ﹤0.01% |
+1,755
| New | +$236K |
|
164
SK Telecom
SKM
$8.38B
| $235K | ﹤0.01% |
11,000
| – | – |
|
165
Noble Corp
NE
$4.54B
| $231K | ﹤0.01% |
4,789
+376
| +9% | +$18.1K |
|
166
Parker-Hannifin
PH
$96.1B
| $230K | ﹤0.01% |
+500
| New | +$230K |
|
|
ORAN
167
DELISTED
Orange
ORAN
| $229K | ﹤0.01% |
20,000
| – | – |
|
168
Darling Ingredients
DAR
$5.07B
| $223K | ﹤0.01% |
4,475
+320
| +8% | +$15.9K |
|
169
Idacorp
IDA
$6.77B
| $216K | ﹤0.01% |
2,200
| – | – |
|
170
Iovance Biotherapeutics
IOVA
$901M
| $205K | ﹤0.01% |
25,200
-1,000
| -4% | -$8.13K |
|
171
Haleon
HLN
$43.9B
| $94.6K | ﹤0.01% |
11,500
| – | – |
|
172
Albemarle
ALB
$9.6B
| – | – |
-3,000
| Closed | -$510K |
|
173
Allegro MicroSystems
ALGM
$5.66B
| – | – |
-12,243
| Closed | -$391K |
|
174
ATS Corp
ATS
$2.67B
| – | – |
-12,307
| Closed | -$527K |
|
175
Anavex Life Sciences
AVXL
$807M
| – | – |
-12,540
| Closed | -$82.1K |
|